Cargando…
Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research
Immortalized cell lines are widely used in vitro tools in oncology and hematology research. While these cell lines represent artificial systems and may accumulate genetic aberrations with each passage, they are still considered valuable models for pilot, preliminary, and screening studies. Despite t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049680/ https://www.ncbi.nlm.nih.gov/pubmed/36982453 http://dx.doi.org/10.3390/ijms24065377 |
_version_ | 1785014511632121856 |
---|---|
author | Skopek, Rafał Palusińska, Małgorzata Kaczor-Keller, Katarzyna Pingwara, Rafał Papierniak-Wyglądała, Anna Schenk, Tino Lewicki, Sławomir Zelent, Artur Szymański, Łukasz |
author_facet | Skopek, Rafał Palusińska, Małgorzata Kaczor-Keller, Katarzyna Pingwara, Rafał Papierniak-Wyglądała, Anna Schenk, Tino Lewicki, Sławomir Zelent, Artur Szymański, Łukasz |
author_sort | Skopek, Rafał |
collection | PubMed |
description | Immortalized cell lines are widely used in vitro tools in oncology and hematology research. While these cell lines represent artificial systems and may accumulate genetic aberrations with each passage, they are still considered valuable models for pilot, preliminary, and screening studies. Despite their limitations, cell lines are cost-effective and provide repeatable and comparable results. Choosing the appropriate cell line for acute myeloid leukemia (AML) research is crucial for obtaining reliable and relevant results. Several factors should be considered when selecting a cell line for AML research, such as specific markers and genetic abnormalities associated with different subtypes of AML. It is also essential to evaluate the karyotype and mutational profile of the cell line, as these can influence the behavior and response to the treatment of the cells. In this review, we evaluate immortalized AML cell lines and discuss the issues surrounding them concerning the revised World Health Organization and the French–American–British classifications. |
format | Online Article Text |
id | pubmed-10049680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100496802023-03-29 Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research Skopek, Rafał Palusińska, Małgorzata Kaczor-Keller, Katarzyna Pingwara, Rafał Papierniak-Wyglądała, Anna Schenk, Tino Lewicki, Sławomir Zelent, Artur Szymański, Łukasz Int J Mol Sci Review Immortalized cell lines are widely used in vitro tools in oncology and hematology research. While these cell lines represent artificial systems and may accumulate genetic aberrations with each passage, they are still considered valuable models for pilot, preliminary, and screening studies. Despite their limitations, cell lines are cost-effective and provide repeatable and comparable results. Choosing the appropriate cell line for acute myeloid leukemia (AML) research is crucial for obtaining reliable and relevant results. Several factors should be considered when selecting a cell line for AML research, such as specific markers and genetic abnormalities associated with different subtypes of AML. It is also essential to evaluate the karyotype and mutational profile of the cell line, as these can influence the behavior and response to the treatment of the cells. In this review, we evaluate immortalized AML cell lines and discuss the issues surrounding them concerning the revised World Health Organization and the French–American–British classifications. MDPI 2023-03-11 /pmc/articles/PMC10049680/ /pubmed/36982453 http://dx.doi.org/10.3390/ijms24065377 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Skopek, Rafał Palusińska, Małgorzata Kaczor-Keller, Katarzyna Pingwara, Rafał Papierniak-Wyglądała, Anna Schenk, Tino Lewicki, Sławomir Zelent, Artur Szymański, Łukasz Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research |
title | Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research |
title_full | Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research |
title_fullStr | Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research |
title_full_unstemmed | Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research |
title_short | Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research |
title_sort | choosing the right cell line for acute myeloid leukemia (aml) research |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049680/ https://www.ncbi.nlm.nih.gov/pubmed/36982453 http://dx.doi.org/10.3390/ijms24065377 |
work_keys_str_mv | AT skopekrafał choosingtherightcelllineforacutemyeloidleukemiaamlresearch AT palusinskamałgorzata choosingtherightcelllineforacutemyeloidleukemiaamlresearch AT kaczorkellerkatarzyna choosingtherightcelllineforacutemyeloidleukemiaamlresearch AT pingwararafał choosingtherightcelllineforacutemyeloidleukemiaamlresearch AT papierniakwygladałaanna choosingtherightcelllineforacutemyeloidleukemiaamlresearch AT schenktino choosingtherightcelllineforacutemyeloidleukemiaamlresearch AT lewickisławomir choosingtherightcelllineforacutemyeloidleukemiaamlresearch AT zelentartur choosingtherightcelllineforacutemyeloidleukemiaamlresearch AT szymanskiłukasz choosingtherightcelllineforacutemyeloidleukemiaamlresearch |